Ana M.
- Country
- Spain
- Department
- N/A
Research Overview
Data & Insights
Has run more than one trial at 7 of 39 partner sites.
Specializations
Hematologic Malignancies
Dr. Ana Mendoza Martínez leads investigations in disorders of blood formation, emphasizing malignant transformations and bone‑marrow failure syndromes.
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Myelodysplastic Syndromes
- Chronic Myeloid Leukemia
- Multiple Myeloma
- Chronic Lymphocytic Leukemia
- Hematopoietic Stem Cell Transplant‑Associated Complications
Clinical activities are centered at the Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz.
Solid Tumor Oncology
Her work extends to a broad spectrum of solid cancers, targeting both common and rare tumor types.
- Non‑Small Cell Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Renal Cell Carcinoma
- Prostate Cancer
- Melanoma
- Sarcoma
- Ovarian Cancer
Therapeutic strategies include targeted agents and immunotherapies evaluated in the Madrid clinical setting.
Immunology & Autoimmune Disorders
She contributes to the study of immune‑mediated diseases, focusing on skin, joint and gastrointestinal manifestations.
- Atopic Dermatitis
- Plaque Psoriasis
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Psoriatic Arthritis
- Crohn’s Disease
- Ulcerative Colitis
- Hidradenitis Suppurativa
Research emphasizes biologic and small‑molecule interventions to modulate pathogenic pathways.
Infectious Diseases
Her portfolio includes investigations of bacterial, viral, and fungal pathogens affecting diverse patient populations.
- Nontuberculous Mycobacterial Lung Infection
- COVID‑19
- Human Immunodeficiency Virus
- Hepatitis B Virus Infection
- Clostridioides difficile Infection
- Cytomegalovirus Reactivation
- Invasive Fungal Infections
- Severe Bacterial Pneumonia
Studies aim to improve antimicrobial stewardship and host‑directed therapies.
Cardiovascular & Metabolic Medicine
She investigates cardiovascular risk and metabolic liver disease, integrating preventive and therapeutic approaches.
- Atherosclerotic Cardiovascular Disease
- Heart Failure with Reduced Ejection Fraction
- Atrial Fibrillation
- Non‑Alcoholic Steatohepatitis
- Type 2 Diabetes Mellitus
- Obesity
- Hypertension
- Peripheral Arterial Disease
Research focuses on novel agents that address inflammation, metabolic dysregulation, and vascular health.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.